Literature DB >> 28940645

Lineage tracing reveals dynamic changes in oligodendrocyte precursor cells following cuprizone-induced demyelination.

Emily G Baxi1, Joseph DeBruin1, Jing Jin1, Hayley J Strasburger1, Matthew D Smith1, Jennifer L Orthmann-Murphy1,2, Jason T Schott1, Amanda N Fairchild1, Dwight E Bergles2, Peter A Calabresi1,2.   

Abstract

The regeneration of oligodendrocytes is a crucial step in recovery from demyelination, as surviving oligodendrocytes exhibit limited structural plasticity and rarely form additional myelin sheaths. New oligodendrocytes arise through the differentiation of platelet-derived growth factor receptor α (PDGFRα) expressing oligodendrocyte progenitor cells (OPCs) that are widely distributed throughout the CNS. Although there has been detailed investigation of the behavior of these progenitors in white matter, recent studies suggest that disease burden in multiple sclerosis (MS) is more strongly correlated with gray matter atrophy. The timing and efficiency of remyelination in gray matter is distinct from white matter, but the dynamics of OPCs that contribute to these differences have not been defined. Here, we used in vivo genetic fate tracing to determine the behavior of OPCs in gray and white matter regions in response to cuprizone-induced demyelination. Our studies indicate that the temporal dynamics of OPC differentiation varies significantly between white and gray matter. While OPCs rapidly repopulate the corpus callosum and mature into CC1 expressing mature oligodendrocytes, OPC differentiation in the cingulate cortex and hippocampus occurs much more slowly, resulting in a delay in remyelination relative to the corpus callosum. The protracted maturation of OPCs in gray matter may contribute to greater axonal pathology and disease burden in MS.
© 2017 Wiley Periodicals, Inc.

Entities:  

Keywords:  demyelination; gray matter; multiple sclerosis; oligodendrocyte progenitor cells; remyelination

Mesh:

Substances:

Year:  2017        PMID: 28940645      PMCID: PMC5761347          DOI: 10.1002/glia.23229

Source DB:  PubMed          Journal:  Glia        ISSN: 0894-1491            Impact factor:   7.452


  44 in total

Review 1.  Myelination and the trophic support of long axons.

Authors:  Klaus-Armin Nave
Journal:  Nat Rev Neurosci       Date:  2010-03-10       Impact factor: 34.870

2.  The translational biology of remyelination: past, present, and future.

Authors:  Robin J M Franklin; Vittorio Gallo
Journal:  Glia       Date:  2014-01-20       Impact factor: 7.452

3.  Fibroblast growth factor signaling in oligodendrocyte-lineage cells facilitates recovery of chronically demyelinated lesions but is redundant in acute lesions.

Authors:  Miki Furusho; Aude J Roulois; Robin J M Franklin; Rashmi Bansal
Journal:  Glia       Date:  2015-04-22       Impact factor: 7.452

4.  Cortical demyelination is prominent in the murine cuprizone model and is strain-dependent.

Authors:  Thomas Skripuletz; Maren Lindner; Alexandra Kotsiari; Niklas Garde; Jantje Fokuhl; Franziska Linsmeier; Corinna Trebst; Martin Stangel
Journal:  Am J Pathol       Date:  2008-03-18       Impact factor: 4.307

5.  Cortical remyelination: a new target for repair therapies in multiple sclerosis.

Authors:  Ansi Chang; Susan M Staugaitis; Ranjan Dutta; Courtney E Batt; Kathryn E Easley; Anthony M Chomyk; V Wee Yong; Robert J Fox; Grahame J Kidd; Bruce D Trapp
Journal:  Ann Neurol       Date:  2012-10-17       Impact factor: 10.422

6.  Extensive remyelination of the CNS leads to functional recovery.

Authors:  I D Duncan; A Brower; Y Kondo; J F Curlee; R D Schultz
Journal:  Proc Natl Acad Sci U S A       Date:  2009-04-02       Impact factor: 11.205

7.  Intracortical multiple sclerosis lesions are not associated with increased lymphocyte infiltration.

Authors:  L Bø; C A Vedeler; H Nyland; B D Trapp; S J Mørk
Journal:  Mult Scler       Date:  2003-08       Impact factor: 6.312

8.  Multimodal imaging of subventricular zone neural stem/progenitor cells in the cuprizone mouse model reveals increased neurogenic potential for the olfactory bulb pathway, but no contribution to remyelination of the corpus callosum.

Authors:  Caroline Guglielmetti; Jelle Praet; Janaki Raman Rangarajan; Ruth Vreys; Nathalie De Vocht; Frederik Maes; Marleen Verhoye; Peter Ponsaerts; Annemie Van der Linden
Journal:  Neuroimage       Date:  2013-08-07       Impact factor: 6.556

9.  Cuprizone treatment induces demyelination and astrocytosis in the mouse hippocampus.

Authors:  Akvile Norkute; Andrea Hieble; Alena Braun; Sonja Johann; Tim Clarner; Werner Baumgartner; Cordian Beyer; Markus Kipp
Journal:  J Neurosci Res       Date:  2009-05-01       Impact factor: 4.164

10.  Astrogliosis during acute and chronic cuprizone demyelination and implications for remyelination.

Authors:  Norah Hibbits; Jun Yoshino; Tuan Q Le; Regina C Armstrong
Journal:  ASN Neuro       Date:  2012-10-30       Impact factor: 4.146

View more
  30 in total

Review 1.  Manipulating oligodendrocyte intrinsic regeneration mechanism to promote remyelination.

Authors:  Fabien Binamé; Lucas D Pham-Van; Dominique Bagnard
Journal:  Cell Mol Life Sci       Date:  2021-05-21       Impact factor: 9.261

2.  Motor learning promotes remyelination via new and surviving oligodendrocytes.

Authors:  Clara M Bacmeister; Helena J Barr; Crystal R McClain; Michael A Thornton; Dailey Nettles; Cristin G Welle; Ethan G Hughes
Journal:  Nat Neurosci       Date:  2020-05-18       Impact factor: 24.884

3.  Methotrexate Chemotherapy Induces Persistent Tri-glial Dysregulation that Underlies Chemotherapy-Related Cognitive Impairment.

Authors:  Erin M Gibson; Surya Nagaraja; Alfonso Ocampo; Lydia T Tam; Lauren S Wood; Praveen N Pallegar; Jacob J Greene; Anna C Geraghty; Andrea K Goldstein; Lijun Ni; Pamelyn J Woo; Ben A Barres; Shane Liddelow; Hannes Vogel; Michelle Monje
Journal:  Cell       Date:  2018-12-06       Impact factor: 41.582

4.  Cuprizone-induced oligodendrocyte loss and demyelination impairs recording performance of chronically implanted neural interfaces.

Authors:  Steven M Wellman; Kelly Guzman; Kevin C Stieger; Lauren E Brink; Sadhana Sridhar; Mitchell T Dubaniewicz; Lehong Li; Franca Cambi; Takashi D Y Kozai
Journal:  Biomaterials       Date:  2020-02-06       Impact factor: 12.479

Review 5.  Diversity and Function of Glial Cell Types in Multiple Sclerosis.

Authors:  Lucas Schirmer; Dorothy P Schafer; Theresa Bartels; David H Rowitch; Peter A Calabresi
Journal:  Trends Immunol       Date:  2021-02-13       Impact factor: 16.687

6.  Neuronal hibernation following hippocampal demyelination.

Authors:  Selva Baltan; Safdar S Jawaid; Anthony M Chomyk; Grahame J Kidd; Jacqueline Chen; Harsha D Battapady; Ricky Chan; Ranjan Dutta; Bruce D Trapp
Journal:  Acta Neuropathol Commun       Date:  2021-03-01       Impact factor: 7.801

Review 7.  Dynamic glial response and crosstalk in demyelination-remyelination and neurodegeneration processes.

Authors:  Tianci Chu; Lisa B E Shields; Wenxin Zeng; Yi Ping Zhang; Yuanyi Wang; Gregory N Barnes; Christopher B Shields; Jun Cai
Journal:  Neural Regen Res       Date:  2021-07       Impact factor: 5.135

8.  Stage-specific control of oligodendrocyte survival and morphogenesis by TDP-43.

Authors:  Dongeun Heo; Jonathan P Ling; Gian C Molina-Castro; Abraham J Langseth; Ari Waisman; Klaus-Armin Nave; Wiebke Möbius; Phil C Wong; Dwight E Bergles
Journal:  Elife       Date:  2022-03-21       Impact factor: 8.713

9.  Analysis of platelet-derived growth factor receptor A and oligodendrocyte transcription factor 2 markers following Hydroxychloroquine administration in animal induced multiple sclerosis model.

Authors:  Hajar Amin Safaei; Seyed Mehdi Eftekhari; Mehdi Aliomrani
Journal:  Metab Brain Dis       Date:  2021-08-03       Impact factor: 3.584

10.  Live imaging of remyelination in the adult mouse corpus callosum.

Authors:  Sara Bottes; Sebastian Jessberger
Journal:  Proc Natl Acad Sci U S A       Date:  2021-07-13       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.